Board appointment at Cadence Pharmaceuticals
This article was originally published in Scrip
Executive Summary
Cadence Pharmaceuticals (US) has elected Michael Eagle to its board of directors. Mr Eagle served as vice-president of manufacturing at Lilly from 1994-2001 and also held a number of executive management positions at the company. Since retiring from Lilly, he has served as a founding member of Barnard Life Sciences, and also serves on the boards of directors at Somaxon Pharmaceuticals, Micrus Endovascular and Cardio Polymers.